Peripheral circulating activated B-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus

Scandinavian Journal of Immunology

Volumn 66, Issue 5, 2007, Pages 584-590

  Dolff, S ^a   Wilde, B ^a   Patschan, S ^a   Durig J ^a   Specker, C ^b   Philipp, T ^a   Kribben, A ^a   Witzke, O ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Eye Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; B7 ANTIGEN; CD137 ANTIGEN; CD27 ANTIGEN; CD38 ANTIGEN; CD71 ANTIGEN; CD86 ANTIGEN; CELL SURFACE MARKER; CYCLOSPORIN A; HYDROXYCHLOROQUINE SULFATE; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL SURFACE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROL GROUP; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HUMAN; KIDNEY; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE SUBPOPULATION; MALE; MOLECULE; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; STIMULATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; ANTIGENS, CD; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PHENOTYPE; PROGNOSIS;

EID: 35348983457     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2007.02008.x     Document Type: Article

References (20)

1. Ndejembi MP, Teijaro JR, Patke DS et al. Control of memory CD4 T cell recall by the CD28/B7 costimulatory pathway. J Immunol 2006 177 : 7698 706.
2. Damle RN, Ghiotto F, Valetto A et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood 2002 99 : 4087 93.
3. DeBenedette MA, Shahinian A, Mak TW, Watts TH. Costimulation of CD28-T lymphocytes by 4-1BB ligand. J Immunol 1997 158 : 551 9.
4. Mittler RS, Foell J, Mc Causland M et al. Anti-CD137 antibodies in the treatment of autoimmune disease and cancer. Immunol Res 2004 29 : 197 208.
5. Chitnis T, Najafian N, Abdallah KA et al. CD28-independent induction of experimental autoimmune encephalomyelitis. J Clin Invest 2001 107 : 575 83.
6. Shi FD, He B, Li H, Matusevicius D, Link H, Ljunggren HG. Differential requirements for CD28 and CD40 ligand in the induction of experimental autoimmune myasthenia gravis. Eur J Immunol 1998 28 : 3587 93.
7. Liang B, Kashgarian M, Sharpe A, Mamula M. Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus. J Immunol 2000 165 : 3436 43.
8. Bijl M, Horst G, Limburg PC, Kallenberg C. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus. Ann Rheum Dis 2001 60 : 523 6.
9. Wu Q, Jinde K, Endoh M, Sakai H. Costimulatory molecules CD80 and CD86 in human crescentic glomerulonephritis. Am J Kidney Dis 2003 41 : 950 61.
10. Odobasic D, Kitching AR, Tipping PG, Holdsworth SR. CD80 and CD86 costimulatory molecules regulate crescentic glomerulonephritis by different mechanisms. Kidney Int 2005 68 : 584 94.
11. Kinoshita K, Tesch G, Schwarting A, Maron R, Sharpe AH, Kelley VR. Costimulation by B7-7 and B7-2 is required for autoimmune disease in MRL-Faslpr mice. J Immunol 2000 164 : 6046 56.
12. Jirapongsananuruk O, Leung DY. The modulation of B7.2 and B7.1 on B cells by immunosuppressive agents. Clin Exp Immunol 1999 118 : 1 8.
13. Orlikowsky TW, Dannecker GE, Spring B, Eichner M, Hoffmann MK, Poets CF. Effect of dexamethasone on B7 regulation and T cell activation in neonates and adults. Pediatr Res 2005 57 : 656 61.
14. Odenthal M, Jacobi A, Hansen A et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol 2000 15 : 5970 9.
15. Boumpas DT, Furie R, Manzi S et al. A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis. Arthritis Rheum 2003 48 : 719 27.
16. Reynolds J, Tam FW, Chandraker A et al. CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis. J Clin Invest 2000 105 : 643 51.
17. Kalled SL, Cutler AH, Burkly LC. Apoptosis and altered dendritic cell homeostasis in lupus nephritis are limited by anti-CD154 treatment. J Immunol 2001 167 : 1740 7.
18. Daikh DI, Finck BK, Linsley PS, Hollenbaugh D, Wofsky D. Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways. J Immunol 1997 159 : 3104 8.
19. Nakajima A, Azuma M, Kodera S et al. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule. Eur J Immunol 1995 25 : 3060 9.
20. Vallerskog T, Gunnarsson I, Widhe M et al. Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. Clin Immunol 2007 122 : 62 74.